Abveris: Abveris Announces Multi-Target, Multi-Year Therapeutic Antibody Discovery Collaboration with Prometheus Biosciences
Abveris today announced that Prometheus Biosciences and Abveris have entered a multi-year collaboration to develop therapeutic antibodies against multiple targets.
Read full article »
Abveris is a Massachusetts-based drug discovery platform that offers solutions such as antibody discovery and screeing for the healthcare industry.
Read more